These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 32091909)

  • 1. Improved Stability of siRNA-Loaded Lipid Nanoparticles Prepared with a PEG-Monoacyl Fatty Acid Facilitates Ligand-Mediated siRNA Delivery.
    Sakurai Y; Mizumura W; Ito K; Iwasaki K; Katoh T; Goto Y; Suga H; Harashima H
    Mol Pharm; 2020 Apr; 17(4):1397-1404. PubMed ID: 32091909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting.
    Sakurai Y; Mizumura W; Murata M; Hada T; Yamamoto S; Ito K; Iwasaki K; Katoh T; Goto Y; Takagi A; Kohara M; Suga H; Harashima H
    Mol Pharm; 2017 Oct; 14(10):3290-3298. PubMed ID: 28789523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S; Sakurai Y; Harashima H
    Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
    Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
    J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.
    Hashiba K; Sato Y; Harashima H
    J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
    Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA.
    Tam YY; Chen S; Zaifman J; Tam YK; Lin PJ; Ansell S; Roberge M; Ciufolini MA; Cullis PR
    Nanomedicine; 2013 Jul; 9(5):665-74. PubMed ID: 23219877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Modular PEG Incorporation Strategies for Stabilization of Peptide-siRNA Nanocomplexes.
    Lo JH; Kwon EJ; Zhang AQ; Singhal P; Bhatia SN
    Bioconjug Chem; 2016 Oct; 27(10):2323-2331. PubMed ID: 27583545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of siRNA Delivery Targeting the Tumor Microenvironment with a New Functional Device].
    Sakurai Y
    Yakugaku Zasshi; 2019; 139(11):1357-1363. PubMed ID: 31685731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core.
    Nakamura T; Yamada K; Fujiwara Y; Sato Y; Harashima H
    Mol Pharm; 2018 Jun; 15(6):2142-2150. PubMed ID: 29668291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.
    Hatakeyama H; Akita H; Ito E; Hayashi Y; Oishi M; Nagasaki Y; Danev R; Nagayama K; Kaji N; Kikuchi H; Baba Y; Harashima H
    Biomaterials; 2011 Jun; 32(18):4306-16. PubMed ID: 21429576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery.
    Hirai Y; Saeki R; Song F; Koide H; Fukata N; Tomita K; Maeda N; Oku N; Asai T
    Int J Pharm; 2020 Jul; 585():119479. PubMed ID: 32473372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA.
    Chen S; Tam YYC; Lin PJC; Sung MMH; Tam YK; Cullis PR
    J Control Release; 2016 Aug; 235():236-244. PubMed ID: 27238441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored Monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-Lipid Alternatives for Stabilization and Delivery of mRNA-Lipid Nanoparticles.
    He X; Payne TJ; Takanashi A; Fang Y; Kerai SD; Morrow JP; Al-Wassiti H; Pouton CW; Kempe K
    Biomacromolecules; 2024 Jul; 25(7):4591-4603. PubMed ID: 38918933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-penetrating peptide-conjugated lipid nanoparticles for siRNA delivery.
    Asai T; Tsuzuku T; Takahashi S; Okamoto A; Dewa T; Nango M; Hyodo K; Ishihara H; Kikuchi H; Oku N
    Biochem Biophys Res Commun; 2014 Feb; 444(4):599-604. PubMed ID: 24486551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model.
    Wong P; Li L; Chea J; Delgado MK; Poku E; Szpikowska B; Bowles N; Minnix M; Colcher D; Wong JYC; Shively JE; Yazaki PJ
    Cancer Biother Radiopharm; 2017 Sep; 32(7):247-257. PubMed ID: 28910151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
    Ishitsuka T; Akita H; Harashima H
    J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophobic Domain Structure of Linear-Dendritic Poly(ethylene glycol) Lipids Affects RNA Delivery of Lipid Nanoparticles.
    Zhou K; Johnson LT; Xiong H; Barrios S; Minnig JT; Yan Y; Abram B; Yu X; Siegwart DJ
    Mol Pharm; 2020 May; 17(5):1575-1585. PubMed ID: 32267707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.